Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction
Hongliang Li(Jiangnan University), Chih‐Chuan Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peter P. Liu(University of Ottawa), Yue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Li-Hong Sun(University Health Network), Dong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qinglin Yang(Morehouse School of Medicine), Hua Cai(University of California, Los Angeles), Ai-Bing Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Minglei Zhuo(University Health Network)
Cited by 108
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837